These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33336774)

  • 1. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
    Hasichaolu ; Zhang X; Li X; Li X; Li D
    Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
    Mulchandani R; Lyngdoh T; Kakkar AK
    Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Quantitative and Functional Changes of Postoperative Peripheral Blood Immune Cell Subsets Relate to Prognosis of Patients with Subarachnoid Hemorrhage: A Preliminary Study.
    Zhou Y; Jiang Y; Peng Y; Zhang M
    World Neurosurg; 2017 Dec; 108():206-215. PubMed ID: 28866066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals.
    Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S
    J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
    Rutkowska E; Kwiecień I; Żabicka M; Maliborski A; Raniszewska A; Kłos K; Urbańska W; Klajnowicz I; Rzepecki P; Chciałowski A
    Viruses; 2021 May; 13(5):. PubMed ID: 34064802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.
    Luo M; Liu J; Jiang W; Yue S; Liu H; Wei S
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32544099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
    Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
    BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Differences of Immunological Parameters Between Severe and Non-severe COVID-19 Patients.
    Li Q; Xu W; Li W; Huang C; Fei L; Xie X; Chen L
    Discov Med; 2021; 31(163):79-87. PubMed ID: 34965375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.